Cargando…
Ancillary Testing in Lung Cancer Diagnosis
The pathologic diagnosis of lung cancer historically has relied primarily on morphologic features of tumors in histologic sections. With the emergence of new targeted therapies, the pathologist is called upon increasingly to provide not only accurate typing of lung cancers, but also to provide progn...
Autores principales: | Dubinski, William, Leighl, Natasha B., Tsao, Ming-Sound, Hwang, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259481/ https://www.ncbi.nlm.nih.gov/pubmed/22263108 http://dx.doi.org/10.1155/2012/249082 |
Ejemplares similares
-
The dawn of a new era, adjuvant EGFR inhibition in resected non-small
cell lung cancer
por: Melosky, Barbara, et al.
Publicado: (2021) -
Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System
por: Makarem, Maisam, et al.
Publicado: (2021) -
Lung cancer in never smokers from the Princess Margaret Cancer Centre
por: Korpanty, Grzegorz J., et al.
Publicado: (2018) -
Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice
por: Martin, Petra, et al.
Publicado: (2017) -
Survey of the use of ancillary tests in the diagnosis of brain stem death
por: Sherrington, A, et al.
Publicado: (2011)